Blood biomarkers for multiple sclerosis: neurofilament light chain and beyond

被引：0
|
作者：
不详
机构：
来源：
EBIOMEDICINE | 2024年 / 104卷
关键词：
D O I：
10.1016/j.ebiom.2024.105214
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis
    Kuhle, J.
    Malmestrom, C.
    Axelsson, M.
    Plattner, K.
    Yaldizli, Oe.
    Derfuss, T.
    Giovannoni, G.
    Kappos, L.
    Lycke, J.
    ACTA NEUROLOGICA SCANDINAVICA, 2013, 128 (06): : E33 - E36
  • [22] Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis
    Bjornevik, Kjetil
    Munger, Kassandra L.
    Cortese, Marianna
    Barro, Christian
    Healy, Brian C.
    Niebuhr, David W.
    Scher, Ann I.
    Kuhle, Jens
    Ascherio, Alberto
    JAMA NEUROLOGY, 2020, 77 (01) : 58 - 64
  • [23] Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis
    Reinert, Marie-Christine
    Benkert, Pascal
    Wuerfel, Jens
    Michalak, Zuzanna
    Ruberte, Esther
    Barro, Christian
    Huppke, Peter
    Stark, Wiebke
    Kropshofer, Harald
    Tomic, Davorka
    Leppert, David
    Kuhle, Jens
    Bruck, Wolfgang
    Gartner, Jutta
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (04):
  • [24] Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis
    Bock, Markus
    Steffen, Falk
    Zipp, Frauke
    Bittner, Stefan
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2022, 9 (01):
  • [25] Multiple sclerosis - Neurofilament light chain antibodies are correlated to cerebral atrophy
    Eikelenboom, MJ
    Petzold, A
    Lazeron, RHC
    Silber, E
    Sharief, M
    Thompson, EJ
    Barkhof, F
    Giovannoni, G
    Polman, CH
    Uitdehaag, BMJ
    NEUROLOGY, 2003, 60 (02) : 219 - 223
  • [26] Neurofilament light chain in human blood is a predictor of disease worsening in relapsing-remitting multiple sclerosis
    Kuhle, J.
    Kropshofer, H.
    Haring, D. A.
    Barro, C.
    Kappos, L.
    Leppert, D.
    Tomic, D.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 298 - 299
  • [27] Neurofilament light chain levels in blood are predictive of cognitive impairment in patients with secondary progressive multiple sclerosis
    Kuhle, J.
    Kropshofer, H.
    Barro, C.
    Meinert, R.
    Haring, D.
    Leppert, D.
    Dahlke, F.
    Tomic, D.
    Kappos, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 666 - 666
  • [28] Including Blood Neurofilament Light Chain in the NEDA Concept in Relapsing-Remitting Multiple Sclerosis Trials
    Sormani, Maria Pia
    Kappos, Ludwig
    Haring, Dieter
    Kropshofer, Harald
    Barro, Christian
    Leppert, David
    Tomic, Davorka
    Kuhle, Jens
    NEUROLOGY, 2018, 90
  • [29] Blood neurofilament light levels segregate treatment effects in multiple sclerosis
    Delcoigne, Benedicte
    Manouchehrinia, Ali
    Barro, Christian
    Benkert, Pascal
    Michalak, Zuzanna
    Kappos, Ludwig
    Leppert, David
    Tsai, Jon A.
    Plavina, Tatiana
    Kieseier, Bernd C.
    Lycke, Jan
    Alfredsson, Lars
    Kockum, Ingrid
    Kuhle, Jens
    Olsson, Tomas
    Piehl, Fredrik
    NEUROLOGY, 2020, 94 (11) : E1201 - E1212
  • [30] Progressive Multiple Sclerosis Biomarkers: Plasma Neurofilament Light Chain and Glial Fibrillary Acidic Protein Levels are Elevated and Correlated
    Schorr, Emily M.
    Gill, Alexander J.
    Smith, Matthew D.
    Valenzuela, Alyssandra
    Thero, Rachel
    Duval, Anna L.
    Winger, Ryan C.
    Graziano, Jasmin
    Harp, Christopher
    Lewis, Alexandria
    Lord, Hannah-Noelle
    Siu, Catherine
    Resto, Yasmin
    Deslauriers, Annaelle
    Bhargava, Pavan
    Saidha, Shiv
    Sotirchos, Elias
    Mowry, Ellen M.
    Calabresi, Peter A.
    Fitzgerald, Kathryn C.
    ANNALS OF NEUROLOGY, 2022, 92 : S146 - S147
12345